![]() Sami-Sabinsa Group Sami-Sabinsa Group (formerly Sami Labs) is a manufacturer and supplier of herbal extracts. | ![]() NGL Fine-Chem NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. | ||||
Founding Date | Founding Date 1979 | Founding Date 1991 | Founding Date 1932 | Founding Date 1949 | Founding Date 1981 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Vadodara, IN HQ | Locations Bengaluru, IN HQ Woolloomooloo, AU Mississauga, CA Nanjing, CN Langen (Hessen), DE Toshima City, JP see more | Locations Warriewood, AU HQ | Locations Mumbai, IN HQ Ankleshwar, IN Aurangabad, IN Boisar, IN Indore, IN Mumbai, IN Navi Mumbai, IN see more | Locations Mumbai, IN HQ |
Employees | Employees 2592% increase | Employees 7211% increase | Employees 1,200 | Employees 17,335 | Employees 380 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $649.5m (FY, 2022) | Revenue (est.) ₹88.5b (FY, 2025) | Revenue (est.) ₹3.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $239.9m (FY, 2022) | Cost of goods ₹28.8b (FY, 2025) | Cost of goods ₹1.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $411.3m (FY, 2022) | Gross profit ₹60.7b (FY, 2025) | Gross profit ₹1.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $38.6m (FY, 2022) | Net income ₹7.9b (FY, 2025) | Net income ₹211.2m (FY, 2025) |

Sami-Sabinsa Group (formerly Sami Labs) is a manufacturer and supplier of herbal extracts.
View company
Ipca Laboratories is a pharmaceutical company.
View company
NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
View company